ACH

Accendra Health Inc

3.17

Jun 25 • 04:00PM ET -0.03 (-0.94%)

Healthcare Medical Distribution USA Micro NYSE

Peers: HSIC COR MCK EVH OMCL PHR HCAT TDOC VEEV PFGC

| Held by: VTI IWM FNDA VXF IWN VFVA SCHA VTWO DFSV DFAT

Index	RUT	P/E	-	EPS (ttm)	-14.06	Insider Own	9.46%	Shs Outstand	76.58M	Perf Week	0.32%
Market Cap	242.77M	Forward P/E	4.16	EPS next Y	0.76	Insider Trans	0.00%	Shs Float	69.34M	Perf Month	14.86%
Enterprise Value	2.08B	PEG	-	EPS next Q	-0.08	Inst Own	82.58%	Short Float	9.58%	Perf Quarter	53.14%
Income	-1.08B	P/S	0.09	EPS this Y	-55.35%	Inst Trans	-8.46%	Short Ratio	8.19	Perf Half Y	18.28%
Sales	2.72B	P/B	-	EPS next Y	69.04%	ROA	-2.90%	Short Interest	6.64M	Perf YTD	13.21%
Book/sh	-6.07	P/C	0.72	EPS next 5Y	-3.33%	ROE	-198.35%	52W High	9.55 -66.81%	Perf Year	-59.67%
Cash/sh	4.40	P/FCF	-	EPS past 3/5Y	- -	ROIC	-96.22%	52W Low	1.84 72.28%	Perf 3Y	-82.99%
Dividend Est.	-	EV/EBITDA	6.04	Sales past 3/5Y	-34.78% -20.10%	Gross Margin	41.32%	Volatility	6.89% 7.96%	Perf 5Y	-92.30%
Dividend TTM	-	EV/Sales	0.76	EPS Y/Y TTM	-196.48%	Oper. Margin	3.47%	ATR (14)	0.25	Perf 10Y	-91.45%
Dividend Ex-Date	Jun 30, 2022	Quick Ratio	0.43	Sales Y/Y TTM	-74.67%	Profit Margin	-39.84%	RSI (14)	54.75	Recom	2.80
Dividend Gr. 3/5Y	- -	Current Ratio	0.49	EPS Q/Q	73.83%	SMA20	7.55%	Beta	1.56	Target Price	4.94
Payout	-	Debt/Eq	-	Sales Q/Q	-76.15%	SMA50	0.35%	Rel Volume	0.43	Prev Close	3.20
Employees	6500	LT Debt/Eq	-	Earnings	May 11 BMO	SMA200	-0.15%	Avg Volume	810.39K	Price	3.17
IPO	Nov 01, 1982	Option/Short	Yes / Yes	EPS/Sales Surpr.	59.31% -2.54%	Trades		Volume	345,754	Change	-0.94%

Date	Action	Analyst	Rating Change	Price Target Change
Nov-03-25	Downgrade	UBS	Buy → Neutral	$4
Jul-19-24	Upgrade	Citigroup	Neutral → Buy	$24 → $19
Feb-26-24	Initiated	Leerink Partners	Market Perform	$24
Jan-03-24	Initiated	Barclays	Equal Weight	$21
Oct-13-22	Downgrade	Citigroup	Buy → Neutral	$52 → $18
Oct-12-22	Downgrade	Robert W. Baird	Outperform → Neutral	$62 → $22
Oct-12-22	Downgrade	BofA Securities	Buy → Underperform	$43 → $17
Apr-26-22	Resumed	Citigroup	Buy	$55
Apr-01-22	Resumed	Credit Suisse	Neutral	$43
Mar-30-22	Resumed	JP Morgan	Underweight	$46
Dec-17-20	Upgrade	UBS	Neutral → Buy	$27 → $37
Sep-25-20	Upgrade	Barclays	Underweight → Equal Weight	$20
Jul-21-20	Upgrade	Robert W. Baird	Neutral → Outperform	$8 → $14
Jul-21-20	Upgrade	BofA Securities	Neutral → Buy	$8 → $12
May-05-20	Downgrade	Robert W. Baird	Outperform → Neutral	$8
Apr-23-20	Resumed	Credit Suisse	Neutral	$8
Jan-21-20	Upgrade	Robert W. Baird	Neutral → Outperform	$9
Sep-06-19	Reiterated	BofA/Merrill	Neutral	$4 → $7.50
Apr-10-19	Reiterated	BofA/Merrill	Neutral	$7 → $4.50
Jan-17-19	Initiated	UBS	Neutral	$8

Show Previous Ratings

Jun-24-26 02:59PM	Alchemy Pay Adds Illinois License as U.S. Regulatory Coverage Reaches 18 States (CryptoProwl)
Jun-23-26 09:15PM	Accendra Health Announces Expiration and Final Results of Offers and Consent Solicitations (Business Wire)
Jun-10-26 06:30AM	Accendra Health Announces Early Results of Offers and Consent Solicitations (Business Wire)
May-22-26 04:01PM	Accendra Health Announces Offers and Consent Solicitations (Business Wire)
May-12-26 03:02AM	Accendra Health Inc (ACH) Q1 2026 Earnings Call Highlights: Navigating Revenue Declines and ... (GuruFocus.com) -17.74%
10:14AM	Loading…
May-11-26 10:14AM	Accendra Health (ACH) Shares Jump After First-Quarter Earnings Beat (InvestorsHub) +8.66%
06:30AM	Accendra Health Reports First Quarter 2026 Financial Results and Announces Comprehensive Balance Sheet Optimization Transaction (Business Wire)
May-01-26 05:00PM	Accendra Health Announces First Quarter 2026 Earnings Release Date and Conference Call (Business Wire)
Feb-24-26 09:32AM	Accendra Health (ACH) Reports 2025 Revenue of $2.8B and Shift Toward Core Home-Based Care (Insider Monkey)
Feb-20-26 12:02AM	Accendra Health Inc (ACH) Q4 2025 Earnings Call Highlights: Navigating Challenges and Strategic ... (GuruFocus.com) +5.24%
Feb-19-26 04:05PM	Accendra Health Reports Fourth Quarter 2025 Financial Results (Business Wire)
Feb-05-26 04:05PM	Accendra Health Announces Fourth Quarter 2025 Earnings Release Date and Conference Call (Business Wire) -5.17% +8.64%
01:35AM	How the Largest IPO of 2025 Could Be Healthy for Your Portfolio (Motley Fool)
Jan-08-26 08:40AM	Implied Volatility Surging for Accendra Health Stock Options (Zacks) +9.77%
Jan-02-26 06:30AM	Accendra Health, Inc. to Begin Trading on NYSE under New Ticker "ACH" (Business Wire) -17.14%
04:05PM	Loading…
Dec-31-25 04:05PM	Owens & Minor, Inc. Completes Sale of Products & Healthcare Services Business to Platinum Equity (Business Wire)
Dec-18-25 04:05PM	Owens & Minor Announces Corporate Name Change to Accendra Health, Inc. (Business Wire) -9.84%
Dec-09-25 09:45AM	Top Insider Purchases in December Signal Market Confidence (24/7 Wall St.)
Dec-05-25 08:22AM	Do Options Traders Know Something About Owens & Minor Stock We Don't? (Zacks)
Dec-02-25 07:00AM	Owens & Minor to Present at Upcoming Investor Conferences on December 2, 2025 (Business Wire)
Nov-11-25 12:30PM	Is Owens & Minors New Focus Enough to Lift Its Shares From the Bottom 100? (Barchart)
Oct-30-25 11:04PM	Owens & Minor Inc (OMI) Q3 2025 Earnings Call Highlights: Strategic Divestiture and Revenue ... (GuruFocus.com) -19.96%
04:05PM	Owens & Minor Reports Third Quarter 2025 Financial Results (Business Wire)
Oct-29-25 09:58AM	Earnings To Watch: Owens & Minor Inc (OMI) Reports Q3 2025 Result (GuruFocus.com)
Oct-28-25 10:00AM	CeriBell, Inc. (CBLL) Expected to Beat Earnings Estimates: Should You Buy? (Zacks)
Oct-23-25 10:00AM	Analysts Estimate Owens & Minor (OMI) to Report a Decline in Earnings: What to Look Out for (Zacks)
Oct-16-25 06:30AM	Owens & Minor Announces Date and Time Change of Third Quarter 2025 Financial Results and Conference Call (Business Wire)
Oct-10-25 08:42AM	OMI Reshapes Portfolio With $375 Million Sale to Platinum Equity (Zacks)
Oct-09-25 09:49AM	Owens & Minor announces sale of P&HS segment for $375m (Hospital Management)
Oct-08-25 06:00AM	Owens & Minor inks $375M deal to sell unit to investment firm (MedTech Dive)
04:21PM	Loading…
Oct-07-25 04:21PM	PLATINUM EQUITY TO ACQUIRE PRODUCTS & HEALTHCARE SERVICES BUSINESS FROM OWENS & MINOR (PR Newswire)
04:15PM	Owens & Minor Announces Definitive Agreement to Divest Products & Healthcare Services Segment to Platinum Equity for $375mm in Cash and a Retained Equity Stake (Business Wire)
05:30AM	Why Hecla Mining Stock Surged in September (Motley Fool)
Sep-15-25 04:45PM	Apria and Byram Join New Optum Preferred DME Network (Business Wire)
Sep-05-25 06:34PM	AppLovin, Robinhood Markets and Emcor Group Set to Join S&P 500; Others to Join S&P 100, S&P MidCap 400 and S&P SmallCap 600 (PR Newswire)
Aug-23-25 03:53AM	UBS Reduces PT on Owens & Minor, Inc. (OMI) from $13 to $7 Following Weaker Q2 2025 Results (Insider Monkey)
Aug-12-25 03:03AM	Owens & Minor Inc (OMI) Q2 2025 Earnings Call Highlights: Navigating Growth Amid Challenges (GuruFocus.com) +18.14%
Aug-11-25 07:00AM	Owens & Minor: Q2 Earnings Snapshot (Associated Press Finance) -34.70%
06:30AM	Owens & Minor Reports Second Quarter 2025 Financial Results (Business Wire)
Aug-09-25 11:02PM	Owens & Minor (OMI) Reports Earnings Tomorrow: What To Expect (StockStory)
Aug-08-25 09:25AM	Owens & Minor Inc (OMI) Q2 2025: Everything You Need To Know Ahead Of Earnings (GuruFocus.com) +12.36%
Aug-07-25 09:15AM	Seeking Clues to Owens & Minor (OMI) Q2 Earnings? A Peek Into Wall Street Projections for Key Metrics (Zacks)
07:55AM	Eli Lilly (LLY) Q2 Earnings and Revenues Surpass Estimates (Zacks)
Aug-05-25 07:45AM	InfuSystems Holdings, Inc. (INFU) Tops Q2 Earnings Estimates (Zacks) -5.65%
Aug-04-25 07:00AM	Owens & Minor Announces Second Quarter 2025 Earnings Release Date and Conference Call (Business Wire) +5.02%
Jul-31-25 05:20PM	ResMed (RMD) Surpasses Q4 Earnings and Revenue Estimates (Zacks) -5.19%
Jul-29-25 02:25PM	Why Owens & Minor (OMI) Stock Is Down Today (StockStory) -5.34%
Jul-14-25 03:20PM	Why Owens & Minor (OMI) Shares Are Trading Lower Today (StockStory)
Jul-11-25 03:31PM	Why Owens & Minor (OMI) Shares Are Sliding Today (StockStory)
Jun-27-25 06:00AM	5 Insightful Analyst Questions From Owens & Minor's Q1 Earnings Call (StockStory) +6.48%
Jun-17-25 12:31AM	1 Russell 2000 Stock to Consider Right Now and 2 to Keep Off Your Radar (StockStory)
Jun-07-25 09:40AM	Owens & Minor price target raised to $7.50 from $7 at BofA (TipRanks)
Jun-06-25 01:50PM	BofA sees termination of OwensRotech deal as surprising but potentially positive (Investing.com) +5.26%
06:23AM	Owens & Minor spikes $1.36B Rotech buyout over regulatory barriers (MedTech Dive)
Jun-05-25 08:11PM	Owens & Minor and Rotech Healthcare Agree to End Previously Planned Acquisition (Insider Monkey) +14.26%
09:00AM	Owens & Minor and Rotech Healthcare Mutually Agree to Terminate Previously Announced Acquisition (Business Wire)
08:41AM	OMI Q1 Earnings Call: Tariff Pressures Mount as Patient Direct Segment Delivers Growth (StockStory)
May-20-25 12:02AM	3 Reasons to Sell OMI and 1 Stock to Buy Instead (StockStory)
May-09-25 08:32AM	Implied Volatility Surging for Owens & Minor Stock Options (Zacks)
03:08AM	Owens & Minor Inc (OMI) Q1 2025 Earnings Call Highlights: Strategic Growth Amidst Tariff ... (GuruFocus.com)
12:32AM	3 Stocks Under $10 Facing Headwinds (StockStory)
May-08-25 10:47PM	Q1 2025 Owens & Minor Inc Earnings Call (Thomson Reuters StreetEvents) -9.92%
07:40AM	Owens & Minor (OMI) Q1 Earnings Top Estimates (Zacks)
06:39AM	Owens & Minor: Q1 Earnings Snapshot (Associated Press Finance)
06:30AM	Owens & Minor Reports First Quarter 2025 Financial Results (Business Wire)
May-07-25 12:07PM	Owens & Minor Q1 2025 Earnings Preview (Seeking Alpha)
10:46AM	Earnings To Watch: Owens & Minor Inc (OMI) Reports Q1 2025 Result (GuruFocus.com)
May-01-25 06:30AM	Owens & Minor Announces First Quarter 2025 Earnings Release Date and Conference Call (Business Wire)
Apr-25-25 05:07AM	3 Reasons OMI is Risky and 1 Stock to Buy Instead (StockStory)
Apr-24-25 04:14PM	Owens & Minor: Lots Of Moving Parts (Seeking Alpha)
Apr-17-25 04:08PM	Owens & Minor: A Painful Transformation (Seeking Alpha) -6.06%
Apr-09-25 04:30PM	Owens & Minor Announces Major Innovations to Products & Healthcare Services Network (Business Wire) -6.04%
10:59AM	Owens & Minor, Inc. (OMI): Among Stocks Insiders Bought in April After Trump's Tariff Rollout (Insider Monkey)
Apr-04-25 08:34AM	Are Options Traders Betting on a Big Move in Owens & Minor (OMI) Stock? (Zacks) -5.01%
Apr-02-25 05:28PM	Owens & Minor Announces Upsize and Pricing of Senior Secured Notes Offering (Business Wire) -6.22%
Mar-26-25 04:44PM	Owens & Minor Announces Launch of Senior Secured Notes Offering (Business Wire)
Mar-25-25 10:42AM	Owens & Minor, Inc. (OMI): Among Stocks Receiving the Most Insider Love in March (InsiderMonkey)
Mar-17-25 09:00AM	1 Healthcare Stock on Our Buy List and 2 to Ignore (StockStory) +5.11%
Mar-01-25 02:06AM	Owens & Minor Inc (OMI) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and ... (GuruFocus.com)
Feb-28-25 11:59PM	Q4 2024 Owens & Minor Inc Earnings Call (Thomson Reuters StreetEvents) +39.04%
01:50PM	Owens & Minor (OMI) Shares Skyrocket, What You Need To Know (StockStory)
07:40AM	Owens & Minor (OMI) Tops Q4 Earnings and Revenue Estimates (Zacks)
07:19AM	Owens & Minor (NYSE:OMI) Reports Q4 In Line With Expectations (StockStory)
06:49AM	Owens & Minor: Q4 Earnings Snapshot (Associated Press Finance)
06:30AM	Owens & Minor Reports Fourth Quarter & Full Year Financial Results and Announces Sale Process Underway for Products & Healthcare Services Segment (Business Wire)
Feb-27-25 10:06AM	Owens & Minor, Inc. (OMI): A Bull Case Theory (Insider Monkey)
08:02AM	Owens & Minor (OMI) Reports Q4: Everything You Need To Know Ahead Of Earnings (StockStory)
07:20AM	What To Expect From Owens & Minor Inc (OMI) Q4 2024 Earnings (GuruFocus.com)
Feb-21-25 10:00AM	Owens & Minor (OMI) Expected to Beat Earnings Estimates: Should You Buy? (Zacks)
Feb-14-25 04:09AM	3 Reasons to Sell OMI and 1 Stock to Buy Instead (StockStory)
Feb-11-25 06:30AM	Owens & Minor Launches ByramConnect Digital Health Platform for Diabetes and Other Chronic Health Conditions (Business Wire)
Feb-07-25 12:10PM	Will Owens & Minor (OMI) Beat Estimates Again in Its Next Earnings Report? (Zacks)
Feb-06-25 08:53AM	Owens & Minor, Inc. (OMI): Among the Best Rebound Stocks to Invest In Now (Insider Monkey)
Feb-04-25 04:36AM	Owens & Minor Shares Plunge 35% as Company Reports Preliminary 2024 Losses (GuruFocus.com)
Feb-03-25 08:09AM	Owens & Minor Stock Dips On Mixed Q4 Preliminary Results & $310 Million Apria Goodwill Charge: Details (Benzinga) -35.18%
06:30AM	Owens & Minor Launches Financing for Rotech Acquisition and Provides Preliminary Fourth Quarter and Full Year 2024 Financial Results Ahead of Investor Meetings (Business Wire)
Dec-02-24 04:15PM	Owens and Minor to Present at Upcoming Investor Conferences (Business Wire)
Nov-22-24 08:42AM	Implied Volatility Surging for Owens & Minor (OMI) Stock Options (Zacks)
Nov-07-24 01:00AM	Owens & Minors Rotech Acquisition: Navigating Integration Challenges and Risks (TipRanks) -6.25%
Nov-06-24 06:25AM	Owens & Minor price target lowered to $18.50 from $21 at Citi (TipRanks) +15.34%

Accendra Health, Inc. engages in the product manufacturing and delivery, home health supply, and perioperative services to support care through the hospital and into the home. Its brands include Apria and Byram Healthcare. The company was founded by Otho O. Owens and G. Gilmer Minor in 1882 and is headquartered in Henrico County, VA.

PresidentMr. Edward A. Pesicka

Executive VPMr. Jonathan A. Leon

Executive VP & COOMr. Perry A. Bernocchi

Executive VPMr. Heath H. Galloway

Vice President of Strategy of Corporate DevelopmentWill Parrish

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Coliseum Capital Management, L	10% Owner	Aug 12 '25	Buy	5.15	720,000	3,708,000	12,282,955	Aug 14 08:23 PM
Coliseum Capital Management, L	10% Owner	Aug 14 '25	Buy	5.31	492,852	2,617,044	13,100,807	Aug 14 08:23 PM
Coliseum Capital Management, L	10% Owner	Aug 13 '25	Buy	5.46	325,000	1,774,500	12,607,955	Aug 14 08:23 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

ACH

Accendra Health Inc

Upgrade your Finviz experience